Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_L02BX
Extra metadata
List of similar endpoints to
L02BX Other hormone antagonists and related agents
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 658 | - | 658 |
| Unadjusted prevalence (%) | 0.25 | - | 0.58 |
| Mean age at first event (years) | 72.22 | - | 72.22 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: RX_L02BX – L02BX Other hormone antagonists and related agents
GWS hits:
before L02BX Other hormone antagonists and related agents
after L02BX Other hormone antagonists and related agents
Loading survival analyses plot
Loading survival analyses table